RhumbLine Advisers’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632K | Sell |
57,308
-4,946
| -8% | -$54.6K | ﹤0.01% | 2529 |
|
|
2025
Q1 | $556K | Buy |
62,254
+2,293
| +4% | +$20.5K | ﹤0.01% | 2506 |
|
|
2024
Q4 | $564K | Sell |
59,961
-3,110
| -5% | -$29.3K | ﹤0.01% | 2604 |
|
|
2024
Q3 | $508K | Sell |
63,071
-14,013
| -18% | -$113K | ﹤0.01% | 2691 |
|
|
2024
Q2 | $654K | Sell |
77,084
-15,095
| -16% | -$128K | ﹤0.01% | 2481 |
|
|
2024
Q1 | $827K | Sell |
92,179
-4,611
| -5% | -$41.4K | ﹤0.01% | 2359 |
|
|
2023
Q4 | $1.09M | Sell |
96,790
-6,376
| -6% | -$71.7K | ﹤0.01% | 2206 |
|
|
2023
Q3 | $890K | Sell |
103,166
-2,473
| -2% | -$21.3K | ﹤0.01% | 2274 |
|
|
2023
Q2 | $1.09M | Buy |
105,639
+19,136
| +22% | +$198K | ﹤0.01% | 2240 |
|
|
2023
Q1 | $939K | Buy |
86,503
+3,145
| +4% | +$34.1K | ﹤0.01% | 2154 |
|
|
2022
Q4 | $935K | Buy |
83,358
+2,730
| +3% | +$30.6K | ﹤0.01% | 2161 |
|
|
2022
Q3 | $818K | Buy |
80,628
+5,748
| +8% | +$58.3K | ﹤0.01% | 2251 |
|
|
2022
Q2 | $678K | Buy |
74,880
+11,697
| +19% | +$106K | ﹤0.01% | 2333 |
|
|
2022
Q1 | $604K | Buy |
63,183
+652
| +1% | +$6.23K | ﹤0.01% | 2338 |
|
|
2021
Q4 | $691K | Buy |
62,531
+1,682
| +3% | +$18.6K | ﹤0.01% | 2368 |
|
|
2021
Q3 | $450K | Buy |
60,849
+2,438
| +4% | +$18K | ﹤0.01% | 2596 |
|
|
2021
Q2 | $848K | Sell |
58,411
-3,104
| -5% | -$45.1K | ﹤0.01% | 2318 |
|
|
2021
Q1 | $1.26M | Sell |
61,515
-3,917
| -6% | -$80K | ﹤0.01% | 2105 |
|
|
2020
Q4 | $1.16M | Buy |
65,432
+3,375
| +5% | +$60K | ﹤0.01% | 2072 |
|
|
2020
Q3 | $918K | Sell |
62,057
-8,800
| -12% | -$130K | ﹤0.01% | 2027 |
|
|
2020
Q2 | $1.49M | Buy |
70,857
+8,413
| +13% | +$177K | ﹤0.01% | 1880 |
|
|
2020
Q1 | $1.44M | Buy |
62,444
+4,528
| +8% | +$105K | ﹤0.01% | 1717 |
|
|
2019
Q4 | $1.5M | Buy |
57,916
+1,141
| +2% | +$29.5K | ﹤0.01% | 1906 |
|
|
2019
Q3 | $1.11M | Sell |
56,775
-295
| -0.5% | -$5.75K | ﹤0.01% | 1992 |
|
|
2019
Q2 | $932K | Buy |
57,070
+1,870
| +3% | +$30.5K | ﹤0.01% | 2090 |
|
|
2019
Q1 | $1.25M | Sell |
55,200
-583
| -1% | -$13.2K | ﹤0.01% | 1934 |
|
|
2018
Q4 | $1.43M | Buy |
55,783
+18,752
| +51% | +$480K | ﹤0.01% | 1840 |
|
|
2018
Q3 | $1.21M | Sell |
37,031
-2,750
| -7% | -$89.9K | ﹤0.01% | 1916 |
|
|
2018
Q2 | $902K | Buy |
39,781
+1,757
| +5% | +$39.8K | ﹤0.01% | 2048 |
|
|
2018
Q1 | $922K | Sell |
38,024
-630
| -2% | -$15.3K | ﹤0.01% | 1977 |
|
|
2017
Q4 | $1.08M | Sell |
38,654
-7,664
| -17% | -$214K | ﹤0.01% | 1912 |
|
|
2017
Q3 | $1.59M | Buy |
46,318
+675
| +1% | +$23.1K | ﹤0.01% | 1749 |
|
|
2017
Q2 | $1.82M | Buy |
45,643
+1,677
| +4% | +$66.8K | ﹤0.01% | 1632 |
|
|
2017
Q1 | $1.62M | Buy |
43,966
+3,142
| +8% | +$116K | ﹤0.01% | 1669 |
|
|
2016
Q4 | $1.3M | Buy |
40,824
+4,229
| +12% | +$135K | ﹤0.01% | 1699 |
|
|
2016
Q3 | $1.33M | Buy |
36,595
+2,573
| +8% | +$93.2K | ﹤0.01% | 1660 |
|
|
2016
Q2 | $772K | Sell |
34,022
-7,711
| -18% | -$175K | ﹤0.01% | 1946 |
|
|
2016
Q1 | $785K | Buy |
41,733
+7,170
| +21% | +$135K | ﹤0.01% | 1953 |
|
|
2015
Q4 | $566K | Buy |
34,563
+925
| +3% | +$15.1K | ﹤0.01% | 2166 |
|
|
2015
Q3 | $370K | Buy |
33,638
+1,854
| +6% | +$20.4K | ﹤0.01% | 2422 |
|
|
2015
Q2 | $414K | Buy |
31,784
+8,810
| +38% | +$115K | ﹤0.01% | 2455 |
|
|
2015
Q1 | $399K | Buy |
22,974
+2,775
| +14% | +$48.2K | ﹤0.01% | 2435 |
|
|
2014
Q4 | $301K | Buy |
20,199
+725
| +4% | +$10.8K | ﹤0.01% | 2576 |
|
|
2014
Q3 | $449K | Sell |
19,474
-1,407
| -7% | -$32.4K | ﹤0.01% | 2276 |
|
|
2014
Q2 | $666K | Buy |
+20,881
| New | +$666K | ﹤0.01% | 2088 |
|